CVS Group plc, a leading provider of veterinary services in the UK, Australia, the Netherlands, and the Republic of Ireland, has announced that certain employees have exercised options under the CVS Group 2020 SAYE Plan and the CVS Group Long Term Incentive Plan 2020. This exercise resulted in the issuance of 211,401 ordinary shares and 6,733 new ordinary shares. The issuance of shares was partially satisfied by the CVS Group Employee Benefit Trust (EBT).

Following the exercise, a total of 645 ordinary shares are held by the EBT, representing approximately 0.001% of the Company's total voting rights. Additionally, 164,101 new ordinary shares were issued to partially satisfy the balance of ordinary shares arising from the SAYE Exercise. These new ordinary shares rank pari passu with the Company's existing ordinary shares.

As a result, the Company now has a total issued share capital of 71,701,763 ordinary shares, each carrying one voting right, with no ordinary shares held in treasury. This figure will be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

CVS Group plc can be contacted through Peel Hunt LLP and Berenberg for financial matters and Camarco for financial PR. The company's CEO is Richard Fairman, and Scott Morrison serves as the Company Secretary.

CVS Group plc operates approximately 500 veterinary practices across its four markets, including specialist referral hospitals, out-of-hours sites, laboratories, crematoria, buying groups, and an online retail business called "Animed Direct." The company is focused on providing high-quality clinical services to its clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy.

This information is provided in accordance with the news released by CVS Group plc on 31 January 2024.